Using a mouse xenograft model, Chang et al. [17] synthesized 2CP, a small compound that specifically binds to CLEC-2 and inhibits podoplanin-induced platelet aggregation in tumor cells without affecting normal hemostasis. The gene discussed is PDPN; the disease is neoplasm.